Download Citation
Article Source:
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication
Nganou-Makamdop K,
Billingsley JM,
Yaffe Z,
O’Connor G,
Tharp GK,
et al.
(2018)
Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication.
PLOS Pathogens 14(8): e1007246.
https://doi.org/10.1371/journal.ppat.1007246